Hosted on MSN
Long-term at-home adaptive deep brain stimulation found to be effective in Parkinson's disease
The Department of Neurology and Neurological Sciences at Stanford University School of Medicine, together with multiple academic medical centers and one industry partner (Medtronic) across the US, ...
The FDA approved Medtronic's BrainSense Adaptive DBS for Parkinson's, offering personalized therapy through automatic adjustments to patients' needs. The ADAPT-PD trial validated aDBS's safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results